VINC
Vincerx Pharma, Inc. Common Stock
VINC
VINC
Delisted
VINC was delisted on the 22nd of April, 2025.
51 hedge funds and large institutions have $18.4M invested in Vincerx Pharma, Inc. Common Stock in 2022 Q2 according to their latest regulatory filings, with 8 funds opening new positions, 15 increasing their positions, 15 reducing their positions, and 22 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
less capital invested
Capital invested by funds: $ → $
Holders
51
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$726K | |
| 2 | +$344K | |
| 3 | +$229K | |
| 4 |
Renaissance Technologies
New York
|
+$226K |
| 5 |
ECM
ExodusPoint Capital Management
New York
|
+$132K |
Top Sellers
| 1 | -$5.52M | |
| 2 | -$906K | |
| 3 | -$858K | |
| 4 |
BlackRock
New York
|
-$830K |
| 5 |
Bank of Montreal
Toronto,
Ontario, Canada
|
-$332K |